lamivudine 中文意思是什麼
lamivudine
解釋
干安能-
As first - line, xolani was taking zidovudine, lamivudine and nevirapine. because azt and 3tc come in a fixed - dose combination, this means he was taking two pills twice daily. xolani s second - line treatment will consist of didanosine, ritonavir - boosted lopinavir lpv r, and tenofovir
素拉利原本服用的第一線藥物包含多夫定（ azt ） 、拉米夫定（ 3tc ）及奈韋拉平（ nvp ） ，其中多夫定及拉米夫定是固定劑量組合，也是說，他原本每天只需服藥兩次，每次兩顆藥丸。 -
Therapy effects of short - term lamivudine treatment on 22 hepa - titis b patients with hbeag - negative
拉米夫定治療兒童和青少年慢性乙型肝炎的長期臨床觀察 -
Combination of lamivudine with other antiviral agents or immune modulators is likely to be more effective
拉米夫啶和其他抗病毒藥物或免疫調節劑聯合使用看起來似乎更有效。 -
The objective of this study was to assess the efficacy and safety of adefovir dipivoxil / adv ( hepsera ) therapy under compassionate use in patients with chronic hepatitis b ( chb ) and lamivudine resistance
本文的目的就是研究阿德福偉在對拉米夫定耐藥的慢性乙肝患者當中使用的安全性和有效性。 -
A 59 - year - old man receiving long - term lamivudine therapy experienced a fatal exacerbation of hepatitis b virus ( hbv ) infection resulting in hepatic necrosis following the emergence of variant hbv
一例長期使用拉米夫定治療的59歲男性患者在hbv變異株出現后乙肝病毒感染發生致命性加重，導致肝壞死。 -
Hbv genotype was determined by the restriction fragment length polymorphism analysis in patients with chronic hbv infection in 5 cities of fujian province. 2. the sensitivities and specialties of melting curve assay and pcr microplate hybridization - elisa assay were compared with mpcr - rflp and sequence analysis for the detection of hbv ymdd mutants in 44 serums from patients receiving lamivudine monitherapy with viral breakthrough
應用熔解曲線法和pcr微板核酸雜交- elisa法對44例接受拉米夫定治療過程中出現病毒學反跳時的血清進行ymdd突變株的檢測，並與測序法和mpcr - rflp法比較它們的敏感性、一致性。 -
Lamivudine therapy for children and teenagers with chronic hepatitis b : a long term clinical observation
復方甘草酸苷聯合拉米夫定治療慢性乙型肝炎的臨床研究 -
Background & aims : one year of lamivudine for chronic hepatitis b results in histologic improvement. we aimed to assess the histological impact of longer - term treatment
背景和目標:對慢性乙肝實行一年拉米夫丁治療后會提高肝臟組織學.我們的目的是觀察長期拉米使用對于組織學的影響 -
Conclusion : low - dose im hbig plus lamivudine provides safe and effective long - term prophylaxis against recurrent hbv at < 10 % the cost of the high - dose regimen
結論：低劑量肌注乙型肝炎免疫球蛋白聯合拉米夫定的使用為長時間的預防hbv復發提供了安全有效的方案並且可使花費小於大劑量用藥方案費用的10 % 。 -
Methods : sets of 3 liver biopsies, from 63 patients before and after 1 year of randomized lamivudine treatment and after 2 years of further open - label treatment, were assigned histologic activity index scores under code
方法:制定三次肝臟穿刺， 63名病人，任選， 1年前，一年後，兩年後（開封）拉米夫丁治療.三次肝穿的紀錄結果是編碼保密的 -
Short - term effect of lamivudine with gan bi tuo treatment in patients with hepatits b
拉米夫定聯合苷必妥治療慢性乙型肝炎病人的近期療效 -
Clinical observation of lamivudine therapy in 50 patients with chronic hepatitis b infection
拉米夫定治療中國慢性乙型肝炎病人2年的臨床研究 -
Treatment of chronic hepatitis b by lamivudine combined with limgzhi capsule : a clinical observation of 30 cases
觀察白擬烏梅敗醬方治療潰瘍性結腸炎 -
Background & aims : adefovir monotherapy is an established treatment modality for lamivudine - experienced patients with chronic hepatitis b, but it carries a significant risk of resistance in the long term
背景與目的：對于拉米夫定治療過的慢性乙肝患者，用阿德福韋酯單藥治療是一種明確的治療模式，但是從長遠觀點來看，這會帶來嚴重的耐藥風險。 -
A study on the clinical and pathological efficacy of lamivudine in the treatment of chronic hepatitis b
陰性的慢性乙型肝炎的長期療效 -
《 international hepatis 》 ： aasld guideline don ' t suggest lamivudine as naive, but in china lamivudine is the classical drug, what do you think of it
國際肝病： aasld指南不推薦拉米夫定作為初始核苷類治療藥物，但是在中國，拉米夫定是經典的抗病毒藥物，你怎麼認為？ -
Xiangtan kaiyuan chemicals co., ltd. is a specialized manufacturer of pharmaceutical intermediates. its products include the intermediates for lamivudine, ziprasidone and olanzapine
湘潭市開元化學有限公司是一家專業生產醫藥中間體的廠家。其產品包括拉米呋啶、齊拉西酮及奧氮平的中間體。 -
Combination of lamivudine and interferon deserves further assessment
拉米夫啶和干擾素聯合治療值得進一步研究。 -
For the patients who had received the preventive treatment with lamivudine, the drug was given before chemotherapy
一組在化療前接受lamivudine ，作為預防性治療。對照組病人沒有接受預防性治療。 -
The rate of hepatitis b virus resistance to adefovir dipivoxil and the evolution of hepatitis b virus in lamivudine - resistant chronic hepatitis b patients with adv monotherapy
阿德福韋治療拉米夫定耐藥慢性乙型肝炎患者的耐藥率及耐藥株進化情況
分享友人